This report provides the reader with a comprehensive analysis of the domestic and international markets involving pharmaceuticals to treat skin diseases and disorders. This edition of Worldwide Market for Prescription Dermatologic Drugs is the fourth time Kalorama Information has comprehensively studied the dermatology markets.
For this latest edition, Kalorama completely re-evaluated the market from the ground up, and in addition to the usual primary interviewing of industry participants, clinicians, and regulators, we also conducted scores of interviews with users of Kalorama’s 2000 and 2002 dermatological studies to ensure that the current report contains the best possible data and the most useful analysis. Some of the reader-inspired changes in the current edition include a greatly expanded exploration of some “hot” topics such as psoriasis and added information on pipeline products in all therapeutic areas.
Market information is available for the years 1998 to 2008, with the focus year 2003. Overview and product descriptions of general adjunctive therapy segments are covered, including prescription drugs to treat:
- Acne and Rosacea
- Antiaging and Photodamage
- Dermatitis and Seborrhea
- Fungal Infections
- Hair Loss and Hair Removal
- Skin Cancer , and
- Other Skin Disorders
Other data points include competitive market share, demographics, epidemiology, and geographic break down. The study covers issues and trends affecting the market, research and developments, and more. In particular, the study explores the current and potential effects of the aging baby boomers on the prescription dermatology market and the continued demand for lifestyle drugs. Profiles of major market participants are included.